Buscar
09/01/2024
Tofacitinib Use in the Treatment of Plantar Erosive Lichen Planus.
Mateu-Arrom L, Garcia-Muret MP, Conforto GC, Puig L. Tofacitinib Use in the Treatment of Plantar Erosive Lichen Planus.. INDIAN JOURNAL OF DERMATOLOGY. 2024; 68(6)DOI:10.4103/ijd.ijd_512_23. PMID:38371534. IF:(Q/D).
08/01/2024
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer
Steinberg, GD, Shore, ND, Redorta, JP, Galsky, MD, Bedke, J, Ku, JH, Kretkowski, M, Hu, HL, Penkov, K, Vermette, JJ, Tarazi, JC, Randall, AE, Pierce, KJ, Saltzstein, D, Powles, TB. CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer. Future Oncology. 2024; 20(14)DOI:10.2217/fon-2023-0271. PMID:38189180. IF:2.600(Q3/6D).
08/01/2024
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Contreras-Toledo, D, Jiménez-Fonseca, P, López, CL, Montes, AF, Muñoz, AML, Rivera, FV, Alonso, V, Alcaide, J, Salvà, F, Rúa, MC, Guillot, M, Carnicero, AM, Mate, RJ, García, SC, Martínez, EA, Astorga, BG, Fernandez-Diaz, AB, Villaroel, PG, Manrique, ACV, Sosa, MM, Alonso, B, Castiñeiras, AC, López, CC, Aparicio, J, Carmona-Bayonas, A. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?. BRITISH JOURNAL OF CANCER. 2024; 130(5)DOI:10.1038/s41416-023-02563-w. PMID:38191609. IF:6.800(Q1/2D).
06/01/2024
Painful flesh-coloured papules in a middle-aged woman
Carmona-Rocha, E, Rusiñol, L, Yélamos, O. Painful flesh-coloured papules in a middle-aged woman. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 49(6)DOI:10.1093/ced/llae007. PMID:38183665. IF:2.800(Q2/4D).
05/01/2024
Pustules, arthritis, and fever in a patient with Crohn's disease
Alturo-Pons, A, Carmona-Rocha, E, Rusiñol, L, Iznardo, H, Puig, L. Pustules, arthritis, and fever in a patient with Crohn's disease. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(6)DOI:10.1111/ijd.17003. PMID:38183159. IF:3.200(Q1/3D).
05/01/2024
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases
del Pozo, V, Bobolea, I, Rial, MJ, Espigol-Frigolé, G, Laqué, RS, Hernández-Rivas, JM, Mora, E, Crespo-Lessmann, A, Alonso, JLI, Sosa, MSD, Maza-Solano, J, Atienza-Mateo, B, Bañas-Conejero, D, Moure, AL, Rúa-Figueroa, I. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases. Frontiers in Immunology. 2024; 14DOI:10.3389/fimmu.2023.1310211. PMID:38250075. IF:5.900(Q1/2D).
04/01/2024
Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective
Lomonte, C, Rossini, M, Ibeas, J, Forcella, M, Ponikvar, JB, Gallieni, M, Russo, R, Goumenos, D, Tesar, V, Hruskova, Z, Roelofs, J, Florquin, S, Snoeijs, M, Giusto, A, Shemesh, D, Rotmans, J, Torra, R, Wanner, C, Gesualdo, L. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective. Clinical Kidney Journal. 2024; 17(1)DOI:10.1093/ckj/sfad299. PMID:38213498. IF:4.600(Q1/2D).
04/01/2024
Severe sperm DNA fragmentation may persist for up to 3 years after cytotoxic therapy in patients affected by Hodgkin lymphoma and non-Hodgkin lymphoma
Farnetani, G, Vannucci, M, Fino, MG, Cioppi, F, Rosta, V, Palma, M, Tamburrino, L, Vinci, S, Casamonti, E, Degl'Innocenti, S, Spinelli, M, Abrardo, C, Marchiani, S, Lotti, F, Muratori, M, Riera-Escamilla, A, Krausz, C. Severe sperm DNA fragmentation may persist for up to 3 years after cytotoxic therapy in patients affected by Hodgkin lymphoma and non-Hodgkin lymphoma. HUMAN REPRODUCTION. 2024; 39(3)DOI:10.1093/humrep/dead269. PMID:38177083. IF:6.100(Q1/1D).